Vaccines Europe - 01 Apr 2020
Today, through EFPIA, the research-based pharmaceutical industry in Europe published a series of commitments as part of the global fight against COVID-19.
Commenting on their publication, EFPIA President and CEO of UCB Pharma Jean-Christophe Tellier said “With Europe at the epicentre of the COVID-19 crisis, the researched-based pharmaceutical industry is coming together to commit its resources, expertise and people to the fight against COVID-19. That means continuing to donate money and in-kind support to health systems, governments and organisations on the ground. It means pulling out every stop to ensure the safe supply of medicines to the patients that need them and working around the clock to find new vaccines, diagnostics and treatments to fight against COVID-19”.
Also commenting on the launch of the commitments, Director General of EFPIA, Nathalie Moll said “In the face of the COVID-19 humanitarian crisis, Europe is coming together in new ways. Our members have been working with health professionals, volunteers and health-systems on the ground, with regulators, Member States and the EU Institutions. The commitments we published today, are our industry’s contribution to that collaborative, collective effort to tackle the coronavirus pandemic. We won’t rest.”
Access the committments here.